CampTek Software Announces Coronavirus Conference Cancellation Bot

PORTLAND, Maine, March 12, 2020 /PRNewswire/ — CampTek Software the leader in Robotic Process Automation (RPA) announced today that it has successfully completed a robot that will automate cancellations and refunds for large conferences around the world. Recently there have been over 260 conferences cancelled as result of the pandemic.

“We are upset to hear about the number of cancellations and the growing disruption this virus is having on the business community.  We feel compelled to do something about this growing crisis,” stated Peter Camp, CTO and Founder of CampTek Software.

As an RPA SaaS Provider, CampTek Software utilizes the UiPath Enterprise Platform with its AI and Machine Learning capabilities to create the Bots that automates this high value function that would take many human workers countless hours. UiPath has recently assisted with speeding up the coronavirus diagnosis time by 50 percent for health providers. 

Regardless of the application, platform and method of delivery, CampTek Software’s expertise and technical backbone will enable them to quickly respond to any need that may arise as a result of the COVID-19 outbreak.

CampTek Software is a RPA SaaS Provider offering a wide array of services to assist you on your RPA Journey. Our team of certified experts focus on Bot development, Bot Support and Hosted Support for our RPA Partners.

Media Contact:
Amy Wooldridge
VP of Operations and Customer Success
CampTek Software
235895@email4pr.com
877.272.0857 x1

View original content to download multimedia:http://www.prnewswire.com/news-releases/camptek-software-announces-coronavirus-conference-cancellation-bot-301022127.html

SOURCE CampTek Software

Staff

Recent Posts

RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- AI/ML health-tech startup Respiree has received approval from the Health…

36 minutes ago

AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore

SINGAPORE, Dec. 7, 2025 /PRNewswire/ -- ChemLex, a next-generation AI-for-science company, today announced the establishment…

36 minutes ago

Is The DEA in Systemic Collapse: Corruption, Constitutional Violations, and a Seven-Year War Against Marijuana Medical Science

The DEA was created to combat cartel trafficking, protect public health, and ensure researchers have…

16 hours ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology…

16 hours ago

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Longer-term analyses reinforce duvelisib’s activity across treatment-experienced PTCL populations, including patients with ≥3 prior lines…

16 hours ago